Scholars Central

Conference abstractPublished 29 Jun 2020

Impact of innovative treatments on economic burden of hepatocellular carcinoma At low middle income countries

Authors: Abdalla Abotaleb

World Health Organisation, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

At low middle income countries like Egypt with prevalence of (HCV) which represent From 5 to 7% of total population. Hepatocellular carcinoma is one of major complications of HCV infection At Africa for example Egypt is accounting for approximately half of the data related to HCC .Over the last two decades, a substantial increase (from 4.0% to 7.2%) in the proportion of chronic liver disease Egyptian patients with HCC was observed. This percentage raise some questions like How government afford innovative products for high number of patients? Are these innovative products worthy for reimbursement? What are the impact on budget? The main objective behind conducting this study was to conduct an economic evaluation of Sorafenib for the treatment of hepatocellular carcinoma in the Egyptian patients, compared to standard of care perspective of the National Fund over a time horizon of 4 years. To maximize health gain for the patients while ensuring the most efficient use of the finite resources available to the Egyptian Ministry of Health. Methods A cost-effectiveness analysis from the payer perspective using Markov chain simulation model which is hypothetical cohort model to conforms to real practice of management of advanced HCC in Egypt. Four years' time horizon was selected to reflect the consequences of a decision. transition probabilities from "first line until progression" state to "best supportive care" and "death" were derived from previously published studies; the SHARP study.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectBusiness & Management
  • SubjectGastroenterology & Hepatology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Abdalla Abotaleb”